These updates have been closed. Thank you for reading. Below you can review the  headlines from Germany  from Wednesday, March 4. German pharmaceutical and biotechnological giant Bayer says it has received preliminary approval from a US court for a deal to settle a class action lawsuit with US plaintiffs .  Tens of thousands of people in the US have attributed the popular weedkiller Roundup and specifically its glyphosate ingredient to cancer. The company has repeatedly said the product is safe.